The Current Ratio of Lytix Biopharma AS (LYTIX.OL) is 3.91.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date | Value |
|---|---|
| 2023-12-31 | 3.91 |
| 2022-12-31 | 8.55 |
| 2021-12-31 | 15.26 |
| 2020-12-31 | 2.57 |
| 2019-12-31 | 4.46 |
| 2018-12-31 | 3.31 |
| 2017-12-31 | 1.33 |